Vivos Inc. (OTCMKTS:RDGL) Sees Large Growth in Short Interest

Vivos Inc. (OTCMKTS:RDGL) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 93,600 shares, an increase of 1,513.8% from the February 13th total of 5,800 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 3,207,700 shares, the short-interest ratio is presently 0.0 days.

Vivos Stock Performance

RDGL traded up $0.00 during trading on Wednesday, reaching $0.12. The stock had a trading volume of 360,833 shares, compared to its average volume of 1,221,905. The business has a 50-day moving average of $0.13 and a 200-day moving average of $0.13. Vivos has a one year low of $0.06 and a one year high of $0.26. The stock has a market cap of $52.86 million, a PE ratio of -11.65 and a beta of 0.89.

Vivos Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.